Dawn of a new era in molecular cancer therapeutics.
Schultz
Richard M
RM
Division of Cancer Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA. Rick_1252@msn.com
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D018579:Patient Selection
D000970:Antineoplastic Agents